185
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The effect of idebenone and corticosteroid treatment on methanol-induced toxic optic nerve and retinal damage in rats: biochemical and histopathological examination

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 250-256 | Received 29 Apr 2022, Accepted 25 Jul 2022, Published online: 05 Aug 2022

References

  • Pakravan M, Esfandiari H, Sanjari N, et al. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. Am J Drug Alcohol Abuse 2016; 42:633–639.
  • Chrysostomou V, Rezania F, Trounce IA, et al. Oxidative stress and mitochondrial dysfunction in glaucoma. Curr Opin Pharmacol 2013;13:12–15.
  • Setiohadji B, Irfani I, Rifada M, et al. The superoxide dismutase mimetic TEMPOL and ıts effect on retinal ganglion cells in experimental methanol-ıntoxicated rats. Ophthalmol Ther 2018;7:167–172.
  • Nakajima Y, Inokuchi Y, Nishi M, et al. Coenzyme Q10 protects retinal cells against oxidative stress in vitro and in vivo. Brain Res 2008;1226:226–233.
  • Lee D, Kim KY, Shim MS, et al. Coenzyme Q10 ameliorates oxidative stress and prevents mitochondrial alteration in ischemic retinal injury. Apoptosis 2014;19:603–614.
  • Ejaz A, Tucker D, Lu Y, et al. Mitochondrial targeted antioxidant in cerebral ischemia. J. Neurol. Neurosci 2015;6:17.
  • Klongpanichapak S, Govitrapong P, Sharma SK, et al. Attenuation of cocaine and methamphetamine neurotoxicity by coenzyme Q10. Neurochem Res 2006;31:303–311.
  • Nishi T, Kitahara H, Iwata Y, et al. Efficacy of combined administration of intracoronary papaverine plus intravenous adenosine 5’-triphosphate in assessment of fractional flow reserve. J Cardiol 2016;68:512–516.
  • Van Hameren G, Campbell G, Deck M, et al. In vivo real-time dynamics of ATP and ROS production in axonal mitochondria show decoupling in mouse models of peripheral neuropathies. Acta Neuropathol Commun 2019;7:86.
  • Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Invest 1976;70:158–169.
  • Skrzydlewska E. Toxicological and metabolic consequences of methanol poisoning. Toxicol Mech Methods 2003;13:277–293.
  • Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351–358.
  • Thaler S, Fiedorowicz M, Rejdak R, et al. Neuroprotective effects of tempol on retinal ganglion cells in a partial optic nerve crush rat model with and without iron load. Exp Eye Res 2010;90:254–260.
  • Ravichandran R, Dudani RA, Almeida AF, et al. Methyl alcohol poisoning (Experience of an outbreak in Bombay). J Postgrad Med 1984;30:69–74.
  • Icel E, Suleyman H, Yazici GN, et al. Effects of adenosine triphosphate on methanol-induced experimental optic nerve damage in rats: biochemical and histopathological evaluation. Cutan Ocul Toxicol 2020;39:244–248.
  • Taşlı NG, Çimen FK, Karakurt Y, et al. Protective effects of Rutin against methanol induced acute toxic optic neuropathy: an experimental study. Int J Ophthalmol 2018;11:780–785.
  • Abrishami M, Khalifeh M, Shoayb M, et al. Therapeutic effects of high-dose intravenous prednisolone in methanol-induced toxic optic neuropathy. J Ocul Pharmacol Ther 2011;27:261–263.
  • Sharpe JA, Hostovsky M, Bilbao JM, et al. Methanol optic neuropathy: a histopathological study. Neurology 1982;32:1093–1100.
  • Sodhi PK, Goyal JL, Mehta DK. Methyl alcohol induced optic neuropathy treated with intravenous high dose steroids. Int J Clin Prac 2001;55:599–602.
  • Shukla M, Shikoh I, Saleem A. Intravenous methylprednisolone could salvage vision in methyl alcohol poisoning. Indian J Ophthalmol 2006; 54:68–69.
  • Fujihara M, Kikuchi M, Kurimot Y. Methanol induced retinal toxicity patient examined by optical coherence tomography. Jpn J Ophthalmol 2006;50:239–241.
  • Seme 3MT, Summerfelt P, Neitz JT, et al. Differential recovery of retinal function after mitochondrial inhibition by methanol intoxication. Invest Ophthalmol Vis Sci 2001;42:834–841.
  • King CE, Rodger J, Bartlett C, et al. Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection. Exp Neurol 2007; 205:48–55.
  • Modarres M, Falavarjani KG, Nazari H, et al. Intravitreal erythropoietin injection for the treatment of non-arteritic anterior ischemic optic neuropathy. Br J Ophthalmol 2011;95:692–695.
  • Naugler WE, Karin M. The wolf in sheep’s clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 2008;14:109–119.
  • McCune LM, Johns T. Antioxidant activity in medicinal plants associated with the symptoms of diabetes mellitus used by the Indigenous Peoples of the North American boreal forest. J Ethnopharmacol 2002;82:197–205.
  • Kukreja RC, Hess ML. The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection. Cardiovasc Res 1992;26:641–655.
  • Sharma K, Ziyadeh FN. Hyperglycemia and diabetic kidney disease: the case for transforming growth factor–β as a key mediator. Diabetes 1995;44:1139–1146.
  • Muthukumar K, Rajakumar S, Sarkar MN, et al. Glutathione peroxidase3 of Saccharomyces cerevisiae protects phospholipids during cadmium-induced oxidative stress. Antonie Van Leeuwenhoek 2011;99:761–771.
  • Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radic Res 2006;40:445–453.
  • Kraut JA, Kurtz I. Toxic alcohol ingestions: clinical features, diagnosis, and management. Clin J Am Soc Nephrol 2008;3:208–225.
  • Hall ED, Braughler JM. Glucocorticoid mechanisms in acute spinal cord injury: a review and therapeutic rationale. Surg Neurol 1982;18:320–327.
  • Sharma R, Marasini S, Sharma AK, et al. Methanol poisoning: ocular and neurological manifestations. Optom Vis Sci 2012; 89:178–182.
  • Sanaei-Zadeh H, Zamani N, Shadnia SH. Outcomes of visual disturbances after methanol poisoning. Clin Toxicol 2011; 49:102–107.
  • Kerimoğlu A, Paşaoğlu O, Kanbak G, et al. Efficiency of coenzyme Q (10) at experimental spinal cord injury. Ulus Travma Acil Cerrahi Derg 2007;13:85–93.
  • Kamzalov S, Sumien N, Forster MJ, et al. Coenzyme Q intake elevates the mitochondrial and tissue levels of Coenzyme Q and alpha-tocopherol in young mice. J Nutr 2003;133:3175–3180.
  • Bullón P, Román-Malo L, Marín-Aguilar F, et al. Lipophilic antioxidants prevent lipopolysaccharide-induced mitochondrial dysfunction through mitochondrial biogenesis improvement. Pharmacol Res 2015;91:1–8.
  • James AM, Smith RA, Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys 2004;423:47–56.
  • Acosta MJ, Vazquez Fonseca L, Desbats MA, et al. Coenzyme Q biosynthesis in health and disease. Biochim Biophys Acta 2016;1857:1079–1085.
  • Turunen M, Olsson J, Dallner G. Metabolism and function of coenzyme Q. Biochim Biophys Acta 2004;1660:171–199.
  • Littarru GP, Tiano L, Belardinelli R, et al. Coenzyme Q(10), endothelial function, and cardiovascular disease. Biofactors 2011; 37:366–373.
  • Davis BM, Tian K, Pahlitzsch M, et al. Topical Coenzyme Q10 demonstrates mitochondrial-mediated neuroprotection in a rodent model of ocular hypertension. Mitochondrion 2017; 36:114–123.
  • Lee D, Shim MS, Kim KY, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress-mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophthalmol Vis Sci 2014; 55:993–1005.
  • Zhang Y, Aberg F, Appelkvist E-L, et al. Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 1995;125:446–453.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.